S
IRWD icon

SignatureFD’s Ironwood Pharmaceuticals IRWD Stock Holding History

SignatureFD’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28K Sell
304
-432
-59% -$1.67K ﹤0.01% 3220
2026
Q1 		$2.58K Buy
+736
New +$3.02K ﹤0.01% 2994
2025
Q1 		– Sell
-652
Closed -$2.89K – 3378
2024
Q4 		$2.89K Buy
+652
New +$2.65K ﹤0.01% 2764
2024
Q2 		– Sell
-1,210
Closed -$10.5K – 3189
2024
Q1 		$10.5K Sell
1,210
-950
-44% -$11.5K ﹤0.01% 2279
2023
Q4 		$24.7K Buy
2,160
+822
+61% +$8.13K ﹤0.01% 1818
2023
Q3 		$12.9K Sell
1,338
-2,676
-67% -$26.2K ﹤0.01% 2074
2023
Q2 		$42.7K Buy
4,014
+841
+27% +$9.04K ﹤0.01% 1519
2023
Q1 		$33.4K Buy
3,173
+2,812
+779% +$31.5K ﹤0.01% 1594
2022
Q4 		$4.47K Sell
361
-93
-20% -$1.05K ﹤0.01% 2525
2022
Q3 		$5K Sell
454
-322
-41% -$3.65K ﹤0.01% 2436
2022
Q2 		$9K Buy
776
+315
+68% +$3.71K ﹤0.01% 2166
2022
Q1 		$6K Buy
461
+41
+10% +$470 ﹤0.01% 2405
2021
Q4 		$5K Hold
420
– – ﹤0.01% 2395
2021
Q3 		$5K Sell
420
-99
-19% -$1.28K ﹤0.01% 2346
2021
Q2 		$7K Buy
519
+111
+27% +$1.27K ﹤0.01% 2149
2021
Q1 		$5K Buy
408
+155
+61% +$1.64K ﹤0.01% 2139
2020
Q4 		$3K Sell
253
-20
-7% -$219 ﹤0.01% 2136
2020
Q3 		$2K Buy
273
+209
+327% +$2.08K ﹤0.01% 2217
2020
Q2 		$1K Buy
+64
New +$655 ﹤0.01% 2321

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SignatureFD's IRWD Position: Q2 2026 in Review

SignatureFD reduced its Ironwood Pharmaceuticals (IRWD) stake by 59% in Q2 2026, selling an estimated $1.67K and leaving 304 shares worth $1.28K. The position accounts for ﹤0.01% of the portfolio, ranked #3220.

SignatureFD first reported a position in IRWD in Q2 2020 and has held it in 19 quarters since. The position peaked at $42.7K in Q2 2023. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • SignatureFD held 304 shares of Ironwood Pharmaceuticals worth $1.28K as of Q2 2026.
  • SignatureFD sold 432 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $1.67K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3220 holding.
  • SignatureFD first reported a position in Ironwood Pharmaceuticals in Q2 2020 and has held it in 19 quarters since.
  • SignatureFD's Ironwood Pharmaceuticals position peaked at $42.7K in Q2 2023.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.